A defect in KCa3.1 channel activity limits the ability of CD8 + T cells from cancer patients to infiltrate an adenosine-rich microenvironment

The limited ability of cytotoxic T cells to infiltrate solid tumors hampers immune surveillance and the efficacy of immunotherapies in cancer. Adenosine accumulates in solid tumors and inhibits tumor-specific T cells. Adenosine inhibits T cell motility through the A receptor (A R) and suppression of KCa3.1 channels. We conducted three-dimensional chemotaxis experiments to elucidate the effect of adenosine on the migration of peripheral blood CD8 T cells from head and neck squamous cell carcinoma (HNSCC) patients. The chemotaxis of HNSCC CD8 T cells was reduced in the presence of adenosine, and the effect was greater on HNSCC CD8 T cells than on healthy donor (HD) CD8 T cells. This response correlated with the inability of CD8 T cells to infiltrate tumors. The effect of adenosine was mimicked by an A R agonist and prevented by an A R antagonist. We found no differences in A R expression, 3',5'-cyclic adenosine monophosphate abundance, or protein kinase A type 1 activity between HNSCC and HD CD8 T cells. We instead detected a decrease in KCa3.1 channel activity, but not expression, in HNSCC CD8 T cells. Activation of KCa3.1 channels by 1-EBIO restored the ability of HNSCC CD8 T cells to chemotax in the presence of adenosine. Our data highlight the mechanism underlying the increased sensitivity of HNSCC CD8 T cells to adenosine and the potential therapeutic benefit of KCa3.1 channel activators, which could increase infiltration of these T cells into tumors.